Felix M. Mottaghy

Aachen, NW, Germany

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 365 publications

Baseline PSMA PET/CT Biomarkers for Patient Selection in [177Lu]Lu-PSMA Radioligand Therapy: Clinical Promise, Methodological Heterogeneity and Future Standardization.

Baseline PSMA PET/CT Biomarkers for Patient Selection in [177Lu]Lu-PSMA Radioligand Therapy: Clinical Promise, Methodological Heterogeneity and Future Standardization.

Journal: Pharmaceuticals (Basel, Switzerland)
Published: June 03, 2026

IDH-genotype-linked kinase rewiring accompanies enhanced therapeutic response to dual-drug ferritin nanocages in high-grade glioma.

IDH-genotype-linked kinase rewiring accompanies enhanced therapeutic response to dual-drug ferritin nanocages in high-grade glioma.

Journal: Materials today. Bio
Published: May 13, 2026

Late post-treatment 131I SPECT/CT reveals additional lymph node metastasis of papillary thyroid carcinoma.

Late post-treatment 131I SPECT/CT reveals additional lymph node metastasis of papillary thyroid carcinoma.

Journal: Nuklearmedizin. Nuclear medicine
Published: May 06, 2026

[18F]FDG PET/CT as an endpoint marker in drug interventional studies in atherosclerosis - a structured review.

[18F]FDG PET/CT as an endpoint marker in drug interventional studies in atherosclerosis - a structured review.

Journal: EJNMMI research
Published: March 27, 2026

Multidisciplinary management of meningiomas in the era of precision oncology.

Multidisciplinary management of meningiomas in the era of precision oncology.

Journal: Nature reviews. Clinical oncology
Published: March 26, 2026

The proportion, clinical predictors, and prognostic impact of hypometabolic estrogen receptor-positive primary breast cancer on baseline [ 18 F] fluorodeoxyglucose PET.

The proportion, clinical predictors, and prognostic impact of hypometabolic estrogen receptor-positive primary breast cancer on baseline [ 18 F] fluorodeoxyglucose PET.

Journal: Nuclear medicine communications
Published: February 26, 2026

PET Molecular Imaging and Theranostics in Lung Diseases: Making Precision Medicine a Reality.

PET Molecular Imaging and Theranostics in Lung Diseases: Making Precision Medicine a Reality.

Journal: Chest
Published: February 10, 2026

Diagnostic Performance of FAPI PET in Patients with Breast Cancer: A Systematic Review.

Diagnostic Performance of FAPI PET in Patients with Breast Cancer: A Systematic Review.

Journal: Journal of nuclear medicine : official publication, Society of Nuclear Medicine
Published: January 30, 2026

Theranostic π Electron-Stabilized Polymeric Micelles for PET Imaging-Guided Drug Delivery to Tumors.

Theranostic π Electron-Stabilized Polymeric Micelles for PET Imaging-Guided Drug Delivery to Tumors.

Journal: Small (Weinheim an der Bergstrasse, Germany)
Published: January 27, 2026

Preliminary Evaluation of 225Ac/177Lu-DOTATATE PRRT in Progressive Meningiomas: Efficacy, Dosimetry, and Imaging Insights.

Preliminary Evaluation of 225Ac/177Lu-DOTATATE PRRT in Progressive Meningiomas: Efficacy, Dosimetry, and Imaging Insights.

Journal: Clinical nuclear medicine
Published: January 26, 2026

Multifunctional theranostic nanocarrier platform for microglia-selective cytochalasin D delivery to modulate neuroinflammation after acute brain injuries.

Multifunctional theranostic nanocarrier platform for microglia-selective cytochalasin D delivery to modulate neuroinflammation after acute brain injuries.

Journal: Biomaterials
Published: January 17, 2026

Diagnostic Efficacy of FAPI-PET/CT Versus [18F]FDG-PET/CT in Upper-Abdominal Malignancies: A Systematic Review and Meta-Analysis.

Diagnostic Efficacy of FAPI-PET/CT Versus [18F]FDG-PET/CT in Upper-Abdominal Malignancies: A Systematic Review and Meta-Analysis.

Journal: Diagnostics (Basel, Switzerland)
Published: January 06, 2026
Showing 1-12 of 365

Last Updated: 09/26/2026